TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19801057

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary rehabilitation program (6-day postoperative in-hospital program including expiratory positive airway pressure mask, bronchial hygiene techniques, progressive distance walking, calisthenics, and cardiopulmonary training)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary rehabilitation program
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 20
Study: 16954990

Group type: EXPERIMENTAL
Intervention: Powered turbinoplasty
Number of subjects: 19

Group type: COMPARATOR
Intervention: Submucosal cauterization
Number of subjects: 19
Study: 15575412

Group type: EXPERIMENTAL
Intervention: automatic method for registering multimodal retinal images
Number of subjects: 24
Study: 12370220

Group type: EXPERIMENTAL
Intervention: Increased plasma von Willebrand factor (vWF) levels
Number of subjects: 1321

Group type: EXPERIMENTAL
Intervention: Increased soluble P-selectin (sP-sel) levels
Number of subjects: 1321

Group type: EXPERIMENTAL
Intervention: Risk stratification based on stroke risk factors
Number of subjects: 1321
Study: 9440718

Group type: EXPERIMENTAL
Intervention: MOPP/ABV hybrid
Number of subjects: 691

Group type: COMPARATOR
Intervention: Sequential MOPP-ABVD
Number of subjects: 691
Study: 7866845

Group type: EXPERIMENTAL
Intervention: Manual therapy with cortisone injections
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standardised conventional and optimised activating treatment
Number of subjects: 101
Study: 2712914

Group type: EXPERIMENTAL
Intervention: Endocervical application of 0.4 mg prostaglandin E2 (PGE2) gel
Number of subjects: 579

Group type: COMPARATOR
Intervention: Intravenous oxytocin infusions
Number of subjects: 579
Study: 329949

Group type: EXPERIMENTAL
Intervention: Amoxycillin
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study: 30414164

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting biliary metal stent with sodium caprate (MSCPM-III)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Covered metal stent (CMS)
Number of subjects: 106
Study: 28289033

Group type: EXPERIMENTAL
Intervention: Pyrazinamide (PZA)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Higher doses of PZA (>50 mg/kg of body weight)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Higher doses of PZA (>80 mg/kg)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Doses in the range of 30 to 40 mg/kg of PZA
Number of subjects: 72
Study: 27097854

Group type: EXPERIMENTAL
Intervention: Copaifera langsdorffii oil resin (CLOR)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Formocresol (FC)
Number of subjects: 64

Group type: COMPARATOR
Intervention: White Mineral Trioxide Aggregate (WMTA)
Number of subjects: 64
Study: 24366852

Group type: EXPERIMENTAL
Intervention: Chair yoga
Number of subjects: 98
Study: 23154555

Group type: EXPERIMENTAL
Intervention: First-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy
Number of subjects: 630

Group type: COMPARATOR
Intervention: Standard inverse sequence (control)
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: First-line erlotinib
Number of subjects: 630

Group type: COMPARATOR
Intervention: Wild-type patients
Number of subjects: 630
Study: 19922895

Group type: EXPERIMENTAL
Intervention: Orally disintegrating tablet (ODT) 5-mg finasteride
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard tablet 5-mg finasteride
Number of subjects: 24
Study: 17966839

Group type: EXPERIMENTAL
Intervention: Single-dose lonafarnib 100 mg under fasted conditions
Number of subjects: 31

Group type: COMPARATOR
Intervention: Single-dose lonafarnib 100 mg under fed conditions
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Multiple-dose lonafarnib 200 mg Q 12 H for 28 days under fasted conditions
Number of subjects: 31

Group type: COMPARATOR
Intervention: Multiple-dose lonafarnib 200 mg Q 12 H for 28 days under fed conditions
Number of subjects: 31
Study: 14987883

Group type: EXPERIMENTAL
Intervention: Autologous renal tumour cell vaccine (six intradermal applications at 4-week intervals postoperatively)
Number of subjects: 379

Group type: COMPARATOR
Intervention: No adjuvant treatment (control group)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Autologous renal tumour cell vaccine
Number of subjects: 379
Study: 11859938

Group type: EXPERIMENTAL
Intervention: 5% perfluoropolyether phosphate (Fomblin HC/P2)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2% perfluoropolyether phosphate (Fomblin HC/P2)
Number of subjects: 20
Study: 9219134

Group type: EXPERIMENTAL
Intervention: Closed wound drainage
Number of subjects: 300

Group type: COMPARATOR
Intervention: No closed wound drainage
Number of subjects: 300
Study: 8423912

Group type: EXPERIMENTAL
Intervention: Cholestyramine, lovastatin, nicotinic acid
Number of subjects: 25

Group type: COMPARATOR
Intervention: DMSO
Number of subjects: 25
Study: 3610519

Group type: EXPERIMENTAL
Intervention: Benzydamine mouthwash
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 0
Study: 29389076

Group type: EXPERIMENTAL
Intervention: Bazedoxifene (20-mg capsule)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ibuprofen (600-mg tablet)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bazedoxifene and Ibuprofen (combined)
Number of subjects: 12
Study: 27365294

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate-impregnated cloths (2%) applied the night before and morning of admission
Number of subjects: 539

Group type: COMPARATOR
Intervention: Standard-of-care antiseptic bathing (soap and water)
Number of subjects: 539
Study: 24925208

Group type: EXPERIMENTAL
Intervention: Tacrolimus and mycophenolic acid
Number of subjects: 58

Group type: COMPARATOR
Intervention: Cyclosporine and mycophenolic acid
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Adverse effects scoring system
Number of subjects: 58
Study: 22439814

Group type: EXPERIMENTAL
Intervention: SchoolSpace intervention involving interaction with a young person with lived experience of mental illness.
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: SchoolSpace intervention
Number of subjects: 7
Study: 20837791

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab injection
Number of subjects: 27

Group type: COMPARATOR
Intervention: Photodynamic therapy (PDT)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 27
Study: 18285414

Group type: EXPERIMENTAL
Intervention: Higher dose l-T(4) (subclinical thyrotoxicosis arm)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Usual dose l-T(4) (euthyroid arm)
Number of subjects: 33
Study: 15871089

Group type: EXPERIMENTAL
Intervention: Tl‐weighted SE sequences
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: STIR sequences
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination of Tl‐weighted and STIR sequences
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Tl‐weighted sequences for low-grade infiltration
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Tl‐weighted sequences for moderate infiltration
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Tl‐weighted sequences for high-grade infiltration
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Application of contrast material with percentage signal increase
Number of subjects: 45
Study: 12866330

Group type: EXPERIMENTAL
Intervention: Audience Response System (ARS)
Number of subjects: 283

Group type: COMPARATOR
Intervention: No Audience Response System (No ARS)
Number of subjects: 283
Study: 10926659

Group type: EXPERIMENTAL
Intervention: Fast incremental running (R) at 90% of VO(2 max)
Number of subjects: 17
Study: 8721699

Group type: EXPERIMENTAL
Intervention: Straight pigtail catheter with preset injection rate (Group IA, n = 46)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Curved pigtail catheter with preset injection rate (Group IIA, n = 48)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Straight pigtail catheter with operator defined injection rate (Group IB, n = 49)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Curved pigtail catheter with operator defined injection rate (Group IIB, n = 45)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Overall group analysis of 190 patients
Number of subjects: 190
Study: 1416324

Group type: EXPERIMENTAL
Intervention: Sodium polystyrene sulfonate and sorbitol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (without sodium polystyrene sulfonate)
Number of subjects: 0
Study: 4014145

Group type: EXPERIMENTAL
Intervention: Education program on diet, smoking, and exercise; personal counseling for high-risk workers.
Number of subjects: 1204

Group type: EXPERIMENTAL
Intervention: Personal counseling for high-risk workers.
Number of subjects: 1204
Study: 31726194

Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan
Number of subjects: 4796

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 4796
Study: 29516699

Group type: EXPERIMENTAL
Intervention: Thunder-fire moxibustion (Moxi) for 30 min, once a day for 14 days.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional nursing (nursing) including health education.
Number of subjects: 60
Study: 27716253

Group type: EXPERIMENTAL
Intervention: Nurse-administered IVI
Number of subjects: 304

Group type: COMPARATOR
Intervention: Physician-administered IVI
Number of subjects: 304
Study: 25521472

Group type: EXPERIMENTAL
Intervention: Standard counseling plus decision aid (DA)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard counseling (SC) alone
Number of subjects: 104
Study: 23835817

Group type: EXPERIMENTAL
Intervention: Prostate cancer screening module
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual education about prostate cancer screening (Control)
Number of subjects: 118
Study: 21183910

Group type: EXPERIMENTAL
Intervention: cytoflavin intravenously in dose 10 ml/day for 5 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: standard intensive therapy for burns
Number of subjects: 60
Study: 17597254

Group type: EXPERIMENTAL
Intervention: Seated provider posture
Number of subjects: 224

Group type: COMPARATOR
Intervention: Standing provider posture
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Both seated and standing provider postures
Number of subjects: 224
Study: 16616941

Group type: EXPERIMENTAL
Intervention: Digital mobile phone exposure (DMP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham exposure to DMP
Number of subjects: 120
Study: 12943490

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10990511

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX‐A)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 8774297

Group type: EXPERIMENTAL
Intervention: Negative media with < 1 pg/mL of endotoxin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Positive media with > or = 1 pg/mL of endotoxin
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Media with > 2 pg/mL of endotoxin
Number of subjects: 100
Study: 1309477

Group type: EXPERIMENTAL
Intervention: 12 g citrus pectin added to a 500 kcal meal with 25 mg beta-carotene
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control meal (500 kcal) with 25 mg beta-carotene without pectin
Number of subjects: 7
Study: 6368491

Group type: EXPERIMENTAL
Intervention: Regional radiotherapy (RT) followed by weekly injection of vinblastine for 2 years
Number of subjects: 1059

Group type: EXPERIMENTAL
Intervention: Splenic irradiation
Number of subjects: 1059

Group type: COMPARATOR
Intervention: Total nodal irradiation (TNI)
Number of subjects: 1059

Group type: EXPERIMENTAL
Intervention: RT + MOPP
Number of subjects: 1059

Group type: EXPERIMENTAL
Intervention: Extended RT (mantle + para‐aortic + spleen treatment)
Number of subjects: 1059

Group type: EXPERIMENTAL
Intervention: TNI or combined modality treatment
Number of subjects: 1059
Study: 30199273

Group type: EXPERIMENTAL
Intervention: Oculus Rift CV1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oculus DK2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Less sensory conflict games (e.g., third‐person platformer games, space and flight simulator games)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VR games with a sense of spatial presence
Number of subjects: 0
Study: 29384173

Group type: EXPERIMENTAL
Intervention: Catechin-enriched green tea (CEGT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Catechin-enriched oolong tea (CEOT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 27019421

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 30
Study: 24971923

Group type: EXPERIMENTAL
Intervention: Occlusal splint therapy for 30 days
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 65
Study: 22339322

Group type: EXPERIMENTAL
Intervention: Media Ready Program
Number of subjects: 412

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 412
Study: 20850054

Group type: EXPERIMENTAL
Intervention: Exposure to thin fashion models
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Exposure to heavier ('plus-sized') models
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Exposure to idealizing images
Number of subjects: 64
Study: 16952975

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 7599

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7599
Study: 15689962

Group type: EXPERIMENTAL
Intervention: Acute tryptophan (TRP) depletion (ATD)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Balanced amino-acid drink (placebo)
Number of subjects: 12
Study: 12165588

Group type: EXPERIMENTAL
Intervention: Breastfeeding promotion intervention modeled on the WHO/UNICEF Baby-Friendly Hospital Initiative
Number of subjects: 17046

Group type: COMPARATOR
Intervention: Control group (then current infant feeding practices)
Number of subjects: 17046

Group type: COMPARATOR
Intervention: Observational analysis of infants weaned in the first month
Number of subjects: 17046

Group type: EXPERIMENTAL
Intervention: Prolonged and exclusive breastfeeding groups
Number of subjects: 17046
Study: 10432134

Group type: EXPERIMENTAL
Intervention: Topical estradiol (E2) cream and pelvic muscle biofeedback training
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo cream and pelvic muscle biofeedback training
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Topical estradiol (E2) cream and sham biofeedback
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo cream and sham biofeedback
Number of subjects: 39
Study: 7576966

Group type: EXPERIMENTAL
Intervention: RT-PCR detection of tyrosine hydroxylase (TH) mRNA
Number of subjects: 0
Study: 1844356

Group type: EXPERIMENTAL
Intervention: Topical mechlorethamine hydrochloride in aqueous vehicle
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Topical mechlorethamine hydrochloride in ointment vehicle
Number of subjects: 6

Group type: COMPARATOR
Intervention: Environmental examination for contamination
Number of subjects: 6
Study: 6406452

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0
Study: 30080424

Group type: EXPERIMENTAL
Intervention: Load-Velocity Profile (LVP)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fixed Sets 20% Velocity Loss Threshold (FSVL20)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Traditional 1RM-Percent-Based Training (PBT)
Number of subjects: 15
Study: 29658370

Group type: EXPERIMENTAL
Intervention: High flavanol high theobromine (HFHT) chocolate
Number of subjects: 131

Group type: COMPARATOR
Intervention: Low flavanol and theobromine chocolate (LFLT)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Chronic HFHT intake
Number of subjects: 131
Study: 27043141

Group type: EXPERIMENTAL
Intervention: Dual n-back working memory training
Number of subjects: 57

Group type: COMPARATOR
Intervention: Active control (processing speed training)
Number of subjects: 57
Study: 24449682

Group type: EXPERIMENTAL
Intervention: Budesonide (1 mg) via mucosal atomization device (MAD) twice a day for 60 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Budesonide via impregnated nasal saline irrigation (INSI) twice a day for 60 days
Number of subjects: 20
Study: 21367551

Group type: EXPERIMENTAL
Intervention: CT arthrography
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: MR arthrography
Number of subjects: 36
Study: 20305852

Group type: EXPERIMENTAL
Intervention: Experimental ceramic suitable for titanium and zirconia frameworks (TEC: 8.5 microm/m*K)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Commercially available low-fusing ceramic optimized for zirconia frameworks (TEC: 9.5 microm/m*K)
Number of subjects: 75
Study: 17571283

Group type: EXPERIMENTAL
Intervention: Advicor (1000/20 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Niacin ER (1000 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lovastatin (20 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Niacin ER (1000 mg) + Lovastatin (20 mg)
Number of subjects: 40
Study: 16392205

Group type: EXPERIMENTAL
Intervention: Transcutaneous suture technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intracutaneous suture technique
Number of subjects: 100
Study: 12057883

Group type: EXPERIMENTAL
Intervention: H. pylori eradication therapy
Number of subjects: 1558

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1558
Study: 10743483

Group type: EXPERIMENTAL
Intervention: High-carbohydrate breakfast with red pepper (10 g)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Mixed diet with red-pepper appetizer (6 g)
Number of subjects: 23

Group type: COMPARATOR
Intervention: High-carbohydrate breakfast
Number of subjects: 23

Group type: COMPARATOR
Intervention: Mixed diet without red-pepper appetizer
Number of subjects: 23
Study: 8535554

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA, aspirin) 75 mg daily
Number of subjects: 19193

Group type: EXPERIMENTAL
Intervention: Calcium antagonist, felodipine, 5 mg once daily
Number of subjects: 19193
Study: 2191582

Group type: EXPERIMENTAL
Intervention: 50 mg isosorbide‐5‐mononitrate (IS‐5‐MN) in sustained-release (SR) form
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 100 mg isosorbide‐5‐mononitrate (IS‐5‐MN) in sustained-release (SR) form
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 6999981

Group type: EXPERIMENTAL
Intervention: High-dose ampicillin (150 mg/kg per day)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Low-dose ampicillin (50 mg/kg per day)
Number of subjects: 96
Study: 29139311

Group type: EXPERIMENTAL
Intervention: Low-intensity physical activity integrated with standard smoking cessation intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care cessation only
Number of subjects: 0
Study: 28716046

Group type: EXPERIMENTAL
Intervention: UTR (Fresenius)
Number of subjects: 50

Group type: COMPARATOR
Intervention: CONV (Conventional dialysis)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: UCR (Nikkiso)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall (all groups)
Number of subjects: 50
Study: 25645425

Group type: COMPARATOR
Intervention: Successful weight losers (SWL)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Overweight (OW) individuals
Number of subjects: 34
Study: 24485005

Group type: EXPERIMENTAL
Intervention: Decision-training educational intervention
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group (instructions only)
Number of subjects: 154
Study: 22989763

Group type: EXPERIMENTAL
Intervention: Peritonsillar infiltration of tramadol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Peritonsillar infiltration of lidocaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 60
Study: 20524462

Group type: EXPERIMENTAL
Intervention: Magnesium infusion (10 mmol of magnesium sulphate dissolved in 100 ml of saline solution infused intravenously over 4 hours, for 3 days)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group (no magnesium infusion)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Magnesium infusion
Number of subjects: 220
Study: 17496236

Group type: EXPERIMENTAL
Intervention: Testosterone patch (5 mg/day) for 2 years
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo for 2 years
Number of subjects: 55
Study: 15383046

Group type: EXPERIMENTAL
Intervention: Left auricular reduction and mitral surgery (Group I)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isolated valve surgery (Group II)
Number of subjects: 50
Study: 11479456

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin
Number of subjects: 970

Group type: EXPERIMENTAL
Intervention: Aggressively dosed statin (simvastatin)
Number of subjects: 970

Group type: EXPERIMENTAL
Intervention: Composite of all-cause mortality, myocardial infarction (MI), and documented refractory ischemia at 7 days
Number of subjects: 970

Group type: EXPERIMENTAL
Intervention: Composite of cardiovascular death, MI, readmission for ACS, and stroke
Number of subjects: 970
Study: 10023277

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (conventional endoscopy)
Number of subjects: 20
Study: 7833098

Group type: EXPERIMENTAL
Intervention: Tropisetron 0.20 mg/kg or more
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 2971708

Group type: EXPERIMENTAL
Intervention: Inhaled VIP (70 micrograms)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (40 micrograms)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Both VIP and Ipratropium bromide
Number of subjects: 6

Group type: COMPARATOR
Intervention: Propranolol (provocative dose)
Number of subjects: 6
Study: 30314505

Group type: EXPERIMENTAL
Intervention: Stand Up intervention (strategies to reduce prolonged sitting)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Sit Less intervention (strategies to reduce total sitting time)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Move More intervention (strategies to increase purposeful walking)
Number of subjects: 134
Study: 28232410

Group type: EXPERIMENTAL
Intervention: Hypertonic saline (7%)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Isotonic saline (0.9%)
Number of subjects: 22
Study: 25741158

Group type: EXPERIMENTAL
Intervention: Pronase and simethicone (Group A)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Simethicone alone (Group B)
Number of subjects: 143